Semaglutide dosing schedule
Human schedule
Semaglutide is administered subcutaneously once weekly. The following is a generalized reference drawn from published studies and clinical GLP-1 titration protocols.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Weeks 1–4 | 0.25 mg weekly | Starting dose |
| Weeks 5–8 | 0.5 mg weekly | Increase if tolerated |
| Weeks 9–16 | 1.0–1.7 mg weekly | Gradual increase |
| From week 17 | 2.4 mg weekly | Maximum in this schedule |